Abstract
I describe a case of tachyphylaxis to pramipexole and its management in a patient with bipolar I disorder.
Keywords: Bipolar, Bipolar depression, Drug holiday, Loss of response, Pramipexole, Tachyphylaxis, Tolerance, caramazepine, lamotrigine, modafinil, quetiapine, Parkinson's disease, valproic acid, depression, antidepressants
Letters in Drug Design & Discovery
Title: Pramipexole Tachyphylaxis and its Management in Bipolar Depression
Volume: 9 Issue: 1
Author(s): Verinder Sharma
Affiliation:
Keywords: Bipolar, Bipolar depression, Drug holiday, Loss of response, Pramipexole, Tachyphylaxis, Tolerance, caramazepine, lamotrigine, modafinil, quetiapine, Parkinson's disease, valproic acid, depression, antidepressants
Abstract: I describe a case of tachyphylaxis to pramipexole and its management in a patient with bipolar I disorder.
Export Options
About this article
Cite this article as:
Sharma Verinder, Pramipexole Tachyphylaxis and its Management in Bipolar Depression, Letters in Drug Design & Discovery 2012; 9 (1) . https://dx.doi.org/10.2174/157018012798193008
DOI https://dx.doi.org/10.2174/157018012798193008 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Synthesis and Evaluation of Anticonvulsant Activity of Some N-[(4-Chlor- 2-methylphenoxy)ethyl]- and N-[(4-Chlor-2-methylphenoxy)acetyl]aminoalkanols
Letters in Drug Design & Discovery Old Weapons for New Wars: Bioactive Molecules From Cnidarian Internal Defense Systems
Central Nervous System Agents in Medicinal Chemistry An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design Bifrontal ECT: A Systematic Review and Meta-Analysis of Efficacy and Cognitive Impact
Current Psychiatry Reviews HDACs and HDAC Inhibitors in Urothelial Carcinoma – Perspectives for an Antineoplastic Treatment
Current Medicinal Chemistry Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Current Drug Metabolism Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders
Current Signal Transduction Therapy Dexmedetomidine Use in General Anaesthesia
Current Drug Targets Translocator Protein Ligands as Promising Therapeutic Tools for Anxiety Disorders
Current Medicinal Chemistry Antiepileptogenic Effect of Retinoic Acid
Current Neuropharmacology Approaching Inherited Disease on a Genomic Scale
Current Genomics GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide
Current Molecular Medicine <i>In Silico</i> Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Current Drug Targets N-Valproyl-L-Tryptophan for CNS-Targeting: Synthesis, Characterization and Efficacy In Vitro Studies of a New Potential Antiepileptic Drug
Medicinal Chemistry Survey of Recent Literature Related to the Biologically Active 4(3H)-Quinazolinones Containing Fused Heterocycles
Current Medicinal Chemistry Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews Pathogens and Chronic or Long-Term Neurologic Disorders
Cardiovascular & Hematological Disorders-Drug Targets Human ABC Transporters at blood-CNS Interfaces as Determinants of CNS Drug Penetration
Current Pharmaceutical Design